Doctors and Researchers at the University of Pittsburgh Medical Center (UMPC) have said they have a vaccine to protect against coronavirus.
The doctors said they were working from Jan 21 to come up with a potential cure for the deadly disease.
The vaccine was developed based on their previous works in creating a vaccine for SARS and MERS.
The new prototype vaccine has been named PittCoVacc and when tested in mice, the researchers found mice had developed antibodies against coronavirus about 2 weeks after receiving the vaccine.
“These two viruses, which are closely related to SARS-CoV-2 (the new coronavirus causing the COVID-19 pandemic), teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus,” said Andrea Gambotto, an associate professor at Pittsburgh.
“SARS CoV-2 is teaching us that it is important to react and (follow) all the way through,”
“We knew exactly where to fight this new virus.”– he added.
The researchers are waiting for federal approval to test the safety measures of the PittCoVacc vaccine.
Federal authorities said it would take 12 to 18 months to come up with the vaccine. Reacting to this researchers say we can’t comment on that and we are waiting for the approval process and can’t give a timeline about the availability.
PittCoVacc is easily scalable to produce in large quantities.
“It also includes a unique delivery method in which hundreds of tiny needles are in a patch similar to a Band-Aid, with the needles, made of sugar and protein particles, dissolving into the skin to deliver the vaccine.” — they said.